Contamination Prevention in Cell Therapy Environments With Kris Wronski

In advanced therapy medicinal products (ATMP) manufacturing, the quality and safety of the product need to be ensured from the first stages of development.

In this episode, we are joined by Kris Wronski, Cell Culture Applications Scientist from Thermo Fisher Scientific. He will discuss how to design an effective contamination prevention strategy that will minimize risks to cell therapy products and allow you to implement appropriate control measures.

By watching this episode you will learn:

• Why contamination prevention strategy is so important

• About the types and sources of particulates in the cell therapy production environment and their impact on product quality and safety

• The role of laboratory equipment in contamination prevention and what to look for when sourcing suitable equipment

Further Reading: 

• Designing an effective contamination prevention strategy 
• Compliance testing demonstrates CO₂ incubator merits certification for use in grade A/B environments